Virtu Financial’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Virtu Financial’s Portfolio BXRX Stock Details BXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41,888	Closed	-$16K	–	2267
2023 Q3	$16K	Buy	+41,888	New	+$23.9K	﹤0.01%	1049
2022 Q4	–	Sell	-2,708	Closed	-$27K	–	2608
2022 Q3	$27K	Buy	2,708 +2,195	+428%	+$51.1K	﹤0.01%	1342
2022 Q2	$17K	Buy	+513	New	+$24K	﹤0.01%	1369
2022 Q1	–	Sell	-122	Closed	-$37K	–	2473
2021 Q4	$37K	Buy	122 +33	+37%	+$20.7K	﹤0.01%	1411
2021 Q3	$70K	Buy	89 +75	+536%	+$65.2K	0.01%	1219
2021 Q2	$15K	Buy	+14	New	+$18.3K	﹤0.01%	1418

Virtu Financial's BXRX Position: Q4 2023 in Review

Virtu Financial sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q4 2023, closing a stake of 41,888 shares — an estimated $16K sold.

Virtu Financial first reported a position in BXRX in Q2 2021 and held it in 6 quarters. The position peaked at $70K in Q3 2021. 2 funds tracked by Wall St. Rank hold BXRX as of Q4 2023.

Virtu Financial reported no remaining Baudax Bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Virtu Financial sold 41,888 Baudax Bio, Inc. Common Stock shares in Q4 2023, an estimated $16K.
Virtu Financial first reported a position in Baudax Bio, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Virtu Financial's Baudax Bio, Inc. Common Stock position peaked at $70K in Q3 2021.
2 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.